Post-approval studies (Phase 4)Study completedNCT01939496
What this trial is testing
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Who this might be right for
Diabetes Mellitus, Type 2Hypertension
Janssen Scientific Affairs, LLC 171